Brookfield Corporation (NYSE: BN): To Buy Or Not To Buy, That Is The Question

Brookfield Corporation (BN) concluded trading on Wednesday at a closing price of $50.45, with 8.69 million shares of worth about $438.42 million changed hands on the day. Half year performance of the stock remained negative as price took a plunge of -4.00% during that period and on April 09, 2025 the price saw a gain of about 12.89%. Currently the company’s common shares owned by public are about 1.51B shares, out of which, 1.24B shares are available for trading.

Stock saw a price change of -7.23% in past 5 days and over the past one month there was a price change of 1.14%. Year-to-date (YTD), BN shares are showing a performance of -12.18% which increased to 24.48% when we look at its performance for past 12 months. Over the period of past 52 weeks, stock dropped to lowest price of $38.18 but also hit the highest price of $62.78 during that period. The average intraday trading volume for Brookfield Corporation shares is 3.06 million. The stock is currently trading -2.38% below its 20-day simple moving average (SMA20), while that difference is down -8.66% for SMA50 and it goes to -4.82% lower than SMA200.

Brookfield Corporation (NYSE: BN) currently have 1.51B outstanding shares and institutions hold larger chunk of about 61.84% of that.

The stock has a current market capitalization of $75.61B and its 3Y-monthly beta is at 1.61. PE ratio of stock for trailing 12 months is 167.61, while it has posted earnings per share of $0.30 in the same period. Its PEG reads 10.82 while making debt-to-equity ratio of 5.42. Volatility of a stock is a metric used to know how much the price of that stock is under influence and for BN, volatility over the week remained 9.86% while standing at 4.83% over the month.

Stock’s fiscal year EPS is expected to drop by -2.78% while it is estimated to increase by 19.67% in next year. EPS is likely to grow at an annualized rate of 15.49% for next 5-years, compared to annual growth of -29.74% made by the stock over the past 5-years.

On March 20, 2023, Credit Suisse Upgrade their recommendations, while on February 06, 2023, Credit Suisse Downgrade their ratings for the stock with a price target of $41.

Most Popular

Related Posts